Introduction
Protein glycosylation is one of the major posttranslational modification (PTM) occurring in eukaryotic cells (from unicellular to multicellular organisms). This PTM which generally follows/ accompanies the synthesis of polypeptides in the endoplasmic reticulum (ER) is initiated in this same compartment, and completed in the Golgi apparatus. Glycosylated proteins follow the secretory pathways and are either released in the extracellular compartments (plasma membrane, cell wall, cell surface matrix) or destined to different organelles within the cell (e.g., lysosomes, vacuoles). Both N-linked and O-linked glycosylation processes have been found and (Wilson Iain, 2002; Kirk Bergstrom and Xia, 2013) studied in plant and animal cells. N-glycosylation is very well described and has been the object of many studies, reviews and biotechnological applications (Strasser, 2009; Bardor et al., 2010; Gomord et al., 2010) , whereas O-glycosylation is less studied in general, and is the focus of this paper. O-glycosylated proteins are known to play important functions in animal and plant cells including cell-cell interactions, signaling, recognition, and scaffolding. Protein glycosylation is also required for maintaining the folding, the stability and the activity of secreted proteins (Apweiler et al., 1999; Haltiwanger and Lowe, 2004) . The structure of O-linked glycans of plant versus animal glycoproteins is quite different (summarized in Fig. 1 ).
In plants, O-glycosylated proteins have been abundantly reported within a family of secreted cell wall proteins, the hydroxyproline-rich glycoproteins (HRGPs). HRGPs constitute a superfamily composed of arabinogalactan-proteins (AGPs), extensins, and proline-rich proteins (Showalter et al., 2010; Xu et al., 2008; Velasquez et al., 2011) . HRGPs are variably glycosylated (Showalter, 1993) . These proteins undergo an essential modification namely the conversion of proline residues into hydroxyproline (Hyp) by a multigene family of enzymes, the prolyl-4-hydroxylases (P4-Hs) (Vlad et al., 2007) that act within the 45 endoplasmic reticulum and the Golgi apparatus. The Hyp residues are then glycosylated either with arabinogalactan chains, with short arabinan chains, or with single galactose residues by different glycosyltransferases in the Golgi apparatus (Shpak et al., 1999; Showalter, 2001; Wilson Iain, 2002; Velasquez et al., 2011; Velasquez et al., 2012) . Molecular genetics approaches coupled to analytical techniques have shown that glycosylation of Hyp residues is dependent on a variety of consensus motifs widespread within the peptide amino acid sequence. O-glycosylation leading to arabinosylation occurs on clustered Ser-(Hyp)4 contiguous sequences (contigs), whereas O-glycosylation leading to arabinogalactosylation occurs on Hyp-alanine, Hyp-serine, Hyp-threonine and Hyp-valine contigs Shpak et al., 2001; Tan et al., 2003; Tan et al., 2004; Estévez et al., 2006; Xu et al., 2008) .
In mammals, O-glycosylation is not predominantly found on proline residues; it does also occur on serine/threonine (Ser/Thr), tyrosine and hydroxylysine amino acids. The most common of these modifications is the mucin-type O-glycosylation, which is widespread in the animal kingdom (Bennett et al., 2012) . In mammals, initiation of mucin-type O-glycosylation can be performed by up to 20 different UDP-GalNac polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) which catalyze the transfer of a single N-acetylgalactosamine (GalNAc) residue to serine/threonine amino acids (GalNAcα Ser/Thr). Further elongation of GalNAc residues is performed by Golgi-located glycosyltransferases and results in different O-glycan structures including core 1 to core 4 structures. Mucin-type O-linked glycoproteins are involved in many biological processes such as the regulation of serum half-life of cytokine, the alteration of glycans on cancer cells and the lubrication of variety of intestinal tissues. Mucins play structural role and contribute to mechanical properties, organization, and shape of tissues, and interact with cells via different receptors. They also regulate their migration, proliferation, and differentiation (Ricard-Blum, 2010) . O-glycosylation has also been well studied on collagen, which is the most abundant proteins in mammals (~30% of total protein mass in certain cells). Collagen contains more than 10% of proline residues. It does also contain lysine residues. The enzymes which hydroxylate these amino acids are the prolylhydroxylase and lysylhydroxylase (Ricard-Blum, 2010; Rosenbloom and Prockop, 1970) .
Understanding O-protein glycosylation has direct implications in basic research but also in several areas of biotechnology, including molecular pharming, or novel strategies of plant/crop protection. Progress in such an understanding has been facilitated by different approaches including molecular genetics and pharmacological approaches. Here, we have chosen to present some drugs/inhibitors which have been used to unravel plant and mammal O-glycosylation. Prospects in application, especially in plant biotechnology, are also presented.
Inhibiting O-glycosylation in plants using chemical inhibitors P4-Hs perform a key step in plant O-glycosylation, which is the hydroxylation of proline residues. Direct or indirect inhibition of the action of this enzyme has been used to study the function of O-glycosylation in plants.
To interfere with the process of O-glycosylation, various substances have been employed including 3,4-dehydro-L-proline (3,4-DHP), ethyl-3,4-dehydroxy benzoate (3,4-EDHB) and α,α-dipyridyl.
3,4-DHP is an analog of proline which can be incorporated into the polypeptide chain, and rapidly and irreversibly inhibits peptidyl proline hydroxylation. 3,4-DHP has been shown to inhibit P4-Hs action in plant cells when applied at micromolar concentrations (Cooper and Varner, 1983) . The authors have shown that treatment of discs of phloem parenchyma tissue from roots of Daucus carota with 5µM and 50µM 3,4-DHP inhibits the hydroxylation of proline by 70% and 90% , respectively. An unpublished study has shown that 3,4-DHP-treated tobacco BY-2 cells were able to alter the molecular weight as well as the carbohydrate composition of secreted AGPs (Aboughe-Angone Sophie, Nguema-Ona Eric, Azeddine Driouich, article in preparation). 3,4-DHP treatment of soybean cells was also shown to induce disappearance of the major PRPs from the cell wall of cultured cells (Schmidt et al., 1991) , and 3,4-DHP-treated protoplasts do not develop osmotic stability and do initiate mitosis. 3,4-DHP-treated carrot root cells continue to synthesize and secrete structurally abnormal extensin HRGPs that might be expected to function abnormally (Cooper et al., 1994) . Others studies showed that treatment of onion root cells by 3, 4-DHP resulted on a 56% decrease in hydroxyproline content (Tullio et al., 1999) . Recently, Xu et al. (2011) , have shown that 3,4-DHP inhibited the proliferation of embryogenic cells of banana and decreased the rate of embryo germination. In the context of plant microbe interactions, 3,4-DHP has been used to investigate the role of plant AGPs in root colonization by soil rhizobacteria (Vicré et al., 2005) . It has been shown that 3,4-DHP induced alteration of AGP glycosylation and altered rhizobacteria ability to colonize Arabidopsis roots (Nguema-Ona et al., 2013) . Altogether, these studies showed that inhibition/alteration of plant O-glycosylation in the plant cells can also be inhibited by ethyl-3,4-dehydroxy benzoate (3-4-EDHB) and α,α-dipyridyl (DP) (Velasquez et al., 2011) . 3,4-EDHB binds to the active site of prolyl4-hydroxylase, while α,α-dipyridyl (DP) chelates a co-factor required for P4-Hs activity. Velazquez et al. have shown that transgenic Arabidopsis roots expressing the fusion LeAGP1::GFP treated at nanomolar range (48 to 219 nM) with these two drugs exhibited 50% growth inhibition of their root hairs. These treatments also caused the accumulation of non-glycosylated ~ 42 KD forms of LeAGP1-GFP and fully O-glycosylated ~ 150 to 200 KD form. The authors also linked the absence of O-glycosylation of extensins in the p4-h Arabidopsis mutants to the abnormal root hair phenotype observed.
Altogether, these studies show that the use of O-glycosylation inhibitors in plants affect considerably various aspects of growth and survival supporting the importance of the O-glycosylation in the function of plant cells.
Inhibiting O-glycosylation in mammals using chemical inhibitors
In mammals, proline, but also serine, threonine, and tyrosine amino acids can be O-glycosylated. Different enzymes perform the addition of glycosidic residues on the polypeptidic backbones. Therefore, different drugs targeting different key enzymes have also been identified and used to study mammal-specific O-glycosylation. Collagens and mucins are well studied mammal-O-glycosylated proteins. Interestingly, collagen O-glycosylation often occurs on Hyp residues while mucin O-glycosylation occurs on serine or threonine residues. Rosenbloom and Prockop (1970) have studied the effect of 3,4-DHP treatment on collagen O-glycosylation. They have found that 3,4-DHP decreased the hydroxylation of proline and lysine residues in collagen and that the altered collagen could not be extruded from cartilage cells as rapidly as that of control samples. The effects observed following 3,4-DHP treatment were comparable to those observed with azetidine-2-carboxylic acid and cis-4-fluoroproline (analog of proline) but were slightly less pronounced . In the study on collagen synthesis and prolyl hydroxylase activity in mammalian cell cultures, Kerwar and Felix (1976) showed that, in addition to decreasing the hydroxylation of proline residues and the secretion of collagen from cells, 3,4-DHP also inhibited the incorporation of glycine and lysine into collagen. 3,4-DHP also prevented excessive collagen deposition during wound healing and inhibited fibrosis development (Kerwar and Felix, 1976) .
By contrast with collagen-type O-glycosylation, mucin-type O-glycosylation occurs on serine and threonine residues, and occurs also on many other glycoproteins (Tarp and Clausen, 2008) . This type of O-glycosylation constitutes the most common type of O-linked glycosylation found in mammals and other eukaryotes (Hang and Bertozzi, 2005) . Here, glycosylation is initiated by the ppGNTases. These are enzymes that initiate mucin-type O-linked glycosylation by transfer of GalNAc from the nucleotide donor Plant Science Today (2015) 2(2): 43-51 47 Fig. 2 . This enzyme plays a pivotal role in cell-cell communication and tissue protection . They have identified a small molecule (1-68A) from a uridine-based library, which inhibits N-acetylgalactosaminyltransferases in mammalian cells and consequently disrupts O-glycosylation. To define the biological roles of the GalNAc-Ts, Tian et al. (2004) subjected NIH3T3 mouse fibroblast cells to 1-68A. The authors observed a marked decrease of protein glycosylation and induction of cell apoptosis. Over-expression of certain isoforms of GalNAc-Ts restored cell surface glycosylation and rescued the inhibitor-induced apoptosis suggesting that the enzymes and O-glycosylation have an important role in the regulation of apoptosis. Also, inhibition of O-glycosylation seems to play a key role in the growth of cancer cells (Patsos et al., 2005) . For instance, benzyl-N-acetyl-a-galactosamide (GalNAc-O-bn) inhibits the O-gylcosylation of KL-6 mucin which is implicated in the development of aggressive metastasis in human pancreatic carcinoma (Xu et al., 2008) .
Comparative functional aspects of plant and mammal O-glycosylated proteins
Plant and mammalian O-glycans are usually considered as structurally different, but the studies of O-glycosylation inhibitors in the mammalian and plant cells show that both plant and animal O-glycosylations are involved in the stability and the conformation of glycoproteins. In the case of extensins, O-glycosylation appears to stabilize the helical conformation whereas incomplete hydroxylation of O-glycosylation would promote a flexible and disorganized conformation (Velasquez et al., 2011) . It has been suggested that O-glycans increase HRGPs solubility and thermal stability as well as resistance to proteolytic degradation (Ferris et al., 2001; Kieliszewski et al., 2010; Lamport et al., 2011) . In recent studies, it has been shown that O-glycosylation of hydroxyproline residues increase the thermal stability of the prolyproline type II helix and the presence of β-O-glycosylated proteins indicated an increase in conformational stability (Owens et al., 2010; Velasquez et al., 2011) . Interestingly plant O-glycosylated proteins are also suggested to play active role in plant defense mechanisms and signaling (Nguema-Ona et al., 2013) . PTMs of O-glycosylated cell wall proteins are important to cell differentiation and plant development. O-glycosylated proteins like arabinogalactan-proteins and extensins are involved in the regulation of plant growth, somatic embryogenesis, and development processes, cell division and cell expansion, reproductive development, biotic and abiotic stress responses, xylem differentiation, and hormone signaling pathways (Seifert and Roberts, 2007; Zhang et al., 2008; Ellis et al., 2010; Velasquez et al., 2011; Xu et al., 2011; Velasquez et al., 2012) . The slightest inhibition or the disruption of this PTM affects the process in which these molecules are involved in plant development. However, O-glycosylation type defines the glycomodules responsible for their shape, size, stability, and biological functions in HRGPs.
These functions are similar in the mammalian cells. Several examples can illustrate the role of O-glycosylation in mammalian cells. In general, O-linked glycans maintain protein stability, heat resistance, antigenicity, cellular interactions, hydrophilicity, and modulation of enzymatic activity and protease resistance by steric hindrance, protein expression and processing (Van den Steen et al., 1998; Wopereis et al., 2006) . O-glycosylation would induce the extended and rigid conformation in the mucin-1 which is a polymorphic, highly glycosylated, type I transmembrane glycoprotein and this allows this molecule to interfere with cell-cell and cell-matrix interactions (Tarp and Clausen, 2008) . Another important function of O-linked sugars is to mediate recognition between proteins. O-glycosylation is also essential for the expression or biological activity of many proteins. For example, O-glycans influence the expression of glycophorin A at the cell surface of human erythrocytes (Remaley et al., 1991) , or the biological activity of interleukin-5 (Kodama et al., 1993) and human lactase phlorizin hydrolase (Naim and Lentze, 1992) . Altered glycosylation directly leads to development of certain diseases such as hematological disorders, Wiskott-Aldrich syndrome and cancer (Tsuboi and Fukuda, 2001; Berger, 1999; Brockhausen, 1999) . O-linked glycans are also known to have an effect on immunologic recognition, for example, the ABO blood group antigens and recognition by antibodies (van den Steen et al., 2000) . In addition, O-glycosidic structures play an important role in the localization and traffic of proteins, and make them more resistant to proteases, increase their stability, avoid or reduce the effects related to oxidation, denaturation by pH, precipitation or aggregation. A specific glycan may be involved in several functions in different places and different times (Varki, 1993) . The different possible functions of O-glycosylation are summarized in Table 1 .
In Table 2 , we summarize also the structure of (Gomord et al., 2010; Sola and Griebenow, 2010; Strasser, 2013) . A recent study has described O-glycosylation of a recombinant human IgA1 expressed in transgenic maize (Karnoup et al., 2005) . Addition of small arabinan chains (via an addition of Hyp residues to the polypeptide sequence) to therapeutic polypeptides expressed in plants was also shown to increase the half-life of the recombinant molecule and its activity.
Plant O-glycosylated proteins such as AGPs have also emerged as interesting players in plant defense against soil pathogens (Nguema-Ona et al., 2013) . Thus, future applied research in plants should evaluate the possibility of massive production of O-glycosylated proteins of interest.
